secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcus Biosciences, Inc. (RCUS)
CIK:        0001724521
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0000950170-23-007320
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arcus Biosciences appoints Alexander Azoy as Principal Accounting Officer
-------------------------------------------------------------------------

- Alexander Azoy appointed Principal Accounting Officer effective March 9, 2023.
- Robert C. Goeltz II remains CFO but ceases as Principal Accounting Officer.
- Azoy previously VP of Finance since Oct 2020; prior CFO at Sienna Biopharmaceuticals.
- Azoy entered standard severance/change of control agreement and severance program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1724521/000095017023007320/0000950170-23-007320-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1724521/000095017023007320/rcus-20230309.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-007320

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer